Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Stemline Therapeutics revenue
Stemline Therapeutics's revenue is $43.2 million.
What is Stemline Therapeutics's revenue?
- Stemline Therapeutics has 100 employees, and the revenue per employee ratio is $432,168.
- Stemline Therapeutics's peak quarterly revenue was $13.3M in 2019(q3).
- Stemline Therapeutics peak revenue was $43.2M in 2019.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Stemline Therapeutics financial information
| CEO | Ivan Bergstein |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 100 |
| Date Founded | 2003 |
| Headquarters | New York, New York |
| Number of Locations | 4 |
| Revenue | $43.2M |
| Net Income | -$76,817,225 |
| Gross Proft | $38.3M (2019) |
| PE Ratio | -4.51 |
| Tax Rate | -0.0% |
| Market Capitalization | $346.6M |
| Total Assets | $186,979,004 |
| Ticker | STML |
Stemline Therapeutics jobs you might like
Stemline Therapeutics financing
Stemline Therapeutics received early financing of $12.5M on 2008-04-09.
| Series | Round size | Date |
|---|---|---|
| Series A | $12.5M | 04/2008 |
| Series Unknown | $1.3M | 03/2010 |
| Series Unknown | $600K | 04/2010 |
| Debt Financing | $740K | 01/2012 |
| Post Ipo Equity | $92M | 01/2019 |
Stemline Therapeutics investors
| Investors | Security type |
|---|---|
| Pequot Capital | Series A |
Search for jobs
Stemline Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Stemline Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Stemline Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Stemline Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Stemline Therapeutics. The data presented on this page does not represent the view of Stemline Therapeutics and its employees or that of Zippia.
Stemline Therapeutics may also be known as or be related to STEMLINE THERAPEUTICS INC, Stemline Therapeutics, Stemline Therapeutics Inc, Stemline Therapeutics Inc. and Stemline Therapeutics, Inc.